Vaginal Health

Menopause, Oestrogen and Vaginal Elasticity: The Hormonal Connection

Menopause is independently associated with vaginal laxity: 52.6 percent of women reporting laxity had been through it, with adjusted odds of 2.23. Here is what falling oestrogen does to the tissue itself, and why dryness and looseness arrive together.

A mature woman sitting calmly in a chair
In this article
Clinical context

This article is general information, not a diagnosis. New, persistent or concerning symptoms should be discussed with your GP or an appropriate healthcare professional.

There is a particular kind of confusion that turns up in a woman’s late forties. Something has changed. Things feel looser, or drier, or both, and there is no event to pin it on: no difficult birth, no injury, sometimes no birth at all.

There is an explanation, and it is one of the least discussed facts about the menopause. Falling oestrogen changes the vaginal tissue itself, not just how well it lubricates, and this shows up clearly in the research: menopause is independently associated with vaginal laxity even once childbirth is accounted for. This article is about what oestrogen was doing to that tissue in the first place, why its withdrawal tends to produce dryness and reduced elasticity together, and where the menopause sits alongside the other causes.

The cause that has nothing to do with childbirth

In a cross-sectional study of 300 women, 52.6 percent of those reporting vaginal laxity had been through the menopause. After the researchers adjusted for the other factors in play, including how many times a woman had given birth, the odds of reporting laxity were 2.23 times higher in menopausal women.

The word adjusted is doing the heavy lifting there. It means this is not childbirth in disguise, quietly showing up in a group of women who happen to be older and to have had more children. The effect survives the statistics. Menopause stands on its own.

For a great many women that is the single most useful sentence on the subject. Vaginal laxity has been culturally filed as a birth injury, which leaves the woman who never gave birth, or who had two straightforward births twenty years ago and recovered well, with a change she can feel and no story that fits it. There is a story. It is a hormonal one.

FactorAdjusted odds of reporting vaginal laxity
One vaginal birth, compared with none2.62 times higher
More than one vaginal birth, compared with none7.14 times higher
Having been through the menopause2.23 times higher

All three figures come from the same study of 300 women, which is why they can be read side by side. Multiple vaginal births carry considerably higher odds than the menopause does, so childbirth remains the largest single mechanical factor. But the menopause figure is not a rounding error, and unlike the others it is not optional.

What oestrogen was holding together

To understand what is lost, it helps to know what is there.

The vagina and the structures around it are supported by two quite different things. The first is muscle: the levator ani, the broad sheet of the pelvic floor slung across the base of the pelvis. The second is connective tissue: the endopelvic fascia, a mesh of collagen fibres interlaced with elastin, smooth muscle, fibroblasts and blood vessels, which anchors the bladder, urethra, vagina and uterus to the pelvic walls.

Connective tissue is roughly 70 to 80 percent collagen, and the type matters more than the total. Type I collagen supplies mechanical strength. Type III supplies elasticity and extensibility, which is the capacity to stretch and then come back. Elastin does what its name suggests. Together these proteins form the extracellular matrix: the scaffolding between the cells that gives tissue its particular combination of give and recoil.

What oestrogen decline is linked to is a change in that scaffolding. Two things are documented. The first is atrophy of the genitourinary tissue. The second is altered gene expression in the vaginal extracellular matrix, which in plain terms means the instructions the cells work from, for building and maintaining that scaffolding, are no longer the instructions they followed before.

Be precise about how strong a claim that is. It is an established association rather than a causal chain mapped step by step in women, and it will not be dressed up here as more. But it is coherent, and it explains something a purely mechanical account of laxity cannot: why the change can arrive in a woman whose pelvic floor has never been stretched by anything.

A mature woman brushing her hair in the morning

Why dryness and reduced elasticity arrive together

Dryness is easier to notice and much easier to name, so it is usually the one that gets raised, if anything gets raised at all. The useful thing to understand is that these are not two separate midlife problems that happen to coincide. They are two visible consequences of one underlying tissue change, and lubrication and elasticity sit downstream of the same wall.

Which means the conversation you may already have been meaning to have about dryness is the same conversation. Not two awkward subjects. One.

There is a third consequence that fewer women connect to the same cause. The connective tissue around the urethra, collagen and elastin together, contributes passively to keeping it closed, entirely independently of any muscular effort. That is part of why continence can shift in midlife in a woman whose pelvic floor muscles are working perfectly well and who has been doing her exercises diligently for years. Some of that closure was never muscular, and squeezing does not reach the part that is not.

Where the menopause sits among the other causes

Causes of laxity stack rather than compete, which is worth saying plainly, because women tend to go looking for the one explanation.

Vaginal childbirth remains the leading mechanical cause: during delivery the levator ani can be overstretched and, in some women, partially or completely detaches from the pubic bone. Delivery also independently reduces the resilience of the pelvic connective tissue. Inherited differences in how the body builds collagen and elastin matter too, as does carrying more weight, and anything that repeatedly loads the pelvic floor from above, such as chronic coughing or long-term straining.

The pattern this produces is common and almost never explained. A woman gives birth in her early thirties, recovers well, notices very little for fifteen years, then finds things changing in her late forties with nothing new having happened. Nothing new has happened. A structure that was remodelled once is going through a second change, which is why so many women arrive at this convinced they must have done something wrong recently. They have not. Two ordinary biological events have landed on the same tissue, decades apart.

Why any of this is worth raising

It is tempting to file this as vanity, particularly at an age when a woman has usually been trained to file quite a lot of things that way. The data do not support that reading.

Vaginal laxity is common. Reported prevalence runs at 31 percent in that cross-sectional study of 300 women and 38 percent in a larger mixed population of 2,621, with a range across the wider literature of 2 to 48 percent. The spread is wide because laxity is a reported sensation rather than a measurement.

Its impact is measurable. In the 300-woman study, women reporting a loose vagina scored significantly worse than women reporting neither loose nor tight on three separate validated instruments: vaginal symptoms, sexual quality of life, and sexual distress. Not marginally worse on one measure, but consistently across all three.

Set that beside the silence. RCOG-commissioned polling found that 69 percent of UK women have never had an NHS professional speak to them about their pelvic floor. A common, quality-of-life-affecting change goes largely undiscussed at precisely the age it becomes most likely, which is exactly the environment in which bad information does well.

Women taking part in a community exercise class

Before anything else, rule things out

This matters more in midlife than at any other point, so it comes before anything about treatment.

Any unexplained bleeding, and particularly any bleeding after the menopause, needs medical assessment rather than an aesthetic appointment. So does unusual or foul-smelling discharge, pelvic pain, or a sensation of heaviness or dragging, which points towards prolapse rather than laxity and is a different clinical problem. Check that your cervical screening is up to date: screening is offered in the UK between the ages of 25 and 64. Undiagnosed abnormal bleeding or pelvic pathology has to be investigated before any energy-based treatment is even on the table, and unresolved cervical abnormalities are a standard reason not to proceed.

If you want somewhere useful to start meanwhile, pelvic floor muscle training is it, with a clear-eyed view of what it does. The evidence that it treats stress urinary incontinence is excellent. The evidence that it reverses laxity is not there, and those two claims deserve different levels of confidence. Do it anyway: a change that is partly connective rather than muscular still leaves the muscular part worth training.

What the evidence on treatment actually says

If you go looking, you will find clinics offering laser or radiofrequency treatment aimed squarely at menopausal vaginal change. Here is what you are entitled to know before you spend anything.

No energy-based device, whether HIFU, radiofrequency or laser, is FDA-approved or NICE-endorsed for vaginal tightening or rejuvenation. The FDA warned in 2018 that the safety and effectiveness of these devices for this indication have not been established. NICE assessed transvaginal laser therapy for urogenital atrophy, which is the menopausal indication specifically, and concluded that evidence on long-term safety and efficacy is inadequate in quality and quantity, so the procedure should be used only in the context of research. And in the largest and most rigorous trial of the technology, a sham-controlled study of fractionated CO2 vaginal laser in 85 women, there was no significant difference between the laser and sham groups at 12 months. For radiofrequency specifically, the most recent meta-analysis rates the evidence insufficient.

That is not a claim that nothing can be done. It is a claim that nobody should be selling you certainty.

If you have been to a GP, the red flags are cleared and the picture is straightforward menopausal change, a consultation at our private clinic is a reasonable next step for an honest assessment. Ask what the evidence for anything suggested does and does not show, and expect a direct answer rather than a brochure. What you should not accept from anyone is the idea that your body has failed at something. It has not. It has simply stopped receiving a hormone it spent forty years building tissue around, and that is worth understanding properly rather than quietly enduring.

A balanced view

What the menopause evidence gives you, and what it does not

What supports it

  • It is an independent cause, not childbirth in disguise: after adjustment for parity and other factors, the odds of reporting laxity were 2.23 times higher in menopausal women
  • It gives an explanation to the many women with no birth injury to point at. In one study of 300 women, 52.6 percent of those reporting laxity had been through the menopause
  • Because dryness and reduced elasticity share a hormonal cause, raising one with a GP naturally opens the other, and genitourinary symptoms of the menopause are a recognised medical matter with an established route to help

Important limitations

  • An association is not a mapped pathway. What is documented is that oestrogen decline is linked to genitourinary tissue atrophy and to altered vaginal extracellular-matrix gene expression, which is some distance from a causal chain measured step by step in women
  • Odds ratios describe populations, not people. Menopause roughly doubles the adjusted odds of reporting laxity, which still leaves a great many women who go through it and notice no change at all
  • The treatments marketed at exactly this problem carry the weakest evidence in the field. NICE classifies transvaginal laser for urogenital atrophy as suitable only in the context of research, and the largest sham-controlled trial found no benefit over placebo at 12 months

Questions, answered plainly

Frequently asked questions

Can you develop vaginal laxity without ever having given birth?

Yes, and the menopause is the clearest reason why. In a cross-sectional study of 300 women, menopause was reported significantly more often among women with laxity, at 52.6 percent, and the adjusted odds of reporting it were 2.23 times higher. That figure is adjusted, meaning it holds after childbirth history is taken into account, so it is not simply parity showing up under another name. Genetics, weight and anything that repeatedly raises abdominal pressure, such as chronic coughing or long-term straining, also contribute independently of birth.

Why have dryness and looseness arrived at the same time?

Because they are two consequences of one change rather than two separate midlife problems. Oestrogen decline at the menopause is linked both to atrophy of genitourinary tissue and to altered gene expression in the vaginal extracellular matrix, which is the collagen and elastin scaffolding that gives tissue its give and its recoil. Lubrication and elasticity are downstream of the same tissue. If you have been treating the dryness as the whole story, the elasticity change is not a separate misfortune, it is the same one.

Will HRT or vaginal oestrogen restore elasticity?

That is a genuine question for a GP, and it is worth asking directly. What the evidence set out here establishes is the link between falling oestrogen and tissue change. It does not tell you how much of that change is reversible, or by how much, and this article will not pretend otherwise. Genitourinary symptoms of the menopause are a recognised medical matter rather than a cosmetic one, so a GP is the right first conversation, not an aesthetic clinic.

When should I see a GP rather than book a treatment?

Straight away, and before anything cosmetic, if you have any unexplained bleeding, particularly bleeding after the menopause, unusual or foul-smelling discharge, pelvic pain, a sensation of heaviness or dragging, persistent incontinence, or if your cervical screening is not up to date. Screening is offered in the UK between the ages of 25 and 64. Undiagnosed abnormal bleeding or pelvic pathology must be investigated before any energy-based treatment is considered at all, and regulators have specifically warned that marketing unproven treatments can keep women from established care.

Does laser or radiofrequency treatment help menopausal vaginal changes?

The honest answer is that it has not been shown to. No energy-based device is FDA-approved or NICE-endorsed for vaginal tightening or rejuvenation. The FDA warned in 2018 that safety and effectiveness for this indication have not been established. NICE assessed transvaginal laser therapy for urogenital atrophy, which is precisely the menopausal indication, and concluded it should be used only in the context of research. The largest sham-controlled trial, of fractionated CO2 vaginal laser in 85 women, found no significant difference from sham at 12 months. Anyone offering you a guarantee here is offering something the evidence cannot support.

Evidence base

Sources and further reading

Selected authoritative and peer-reviewed sources used to inform this article.

  1. Vaginal laxity: prevalence, risk factors and impactThe Journal of Sexual Medicine
  2. Local oestrogen for pelvic floor disordersCochrane review / PubMed Central
  3. Vaginal wall biomechanical properties and menopausePubMed
Rosalie Parker

About the author

Rosalie Parker

Rosalie Parker, BSc (Hons), is a writer and aesthetic consultant. A veteran freelance writer within the beauty industry and a mainstay at UK aesthetic expositions, since 2023 Rosalie has consulted and written for a leading aesthetic clinic.